TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease
Seyedeh M. Zekavat, Vanesa Viana‐Huete, Nuria Matesanz, Saman Doroodgar Jorshery, María A. Zuriaga, Md Mesbah Uddin, Mark Trinder, Kaavya Paruchuri, Virginia Zorita, Alba Ferrer-Pérez, Marta Amorós-Pérez, Paolo Kunderfranco, Roberta Carriero, Carolina M. Greco, Alejandra Aroca-Crevillén, Andrés Hidalgo, Scott M. Damrauer, Christie M. Ballantyne, Abhishek Niroula, Christopher J. Gibson, James P. Pirruccello, Gabriel K. Griffin, Benjamin L. Ebert, Peter Libby, Valentı́n Fuster, Hongyu Zhao, Marzyeh Ghassemi, Pradeep Natarajan, Alexander G. Bick, José J. Fuster, Derek Klarin
Topics & Concepts
HaematopoiesisDiseaseAtherosclerotic cardiovascular diseaseMedicineImmunologyBiologyInternal medicineGeneticsStem cellAcute Myeloid Leukemia ResearchSingle-cell and spatial transcriptomicsCancer Genomics and Diagnostics